Medications

Tretten approved for genetic clotting disorder

(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.

Medical research

Researchers discover a new player in tumor suppression and aging

A study conducted by the Spanish National Cancer Research Centre´s (CNIO) Genomic Instability Group, led by Óscar Fernández-Capetillo, describes for the first time in mammals, the role played by the SMC5/6 protein complex ...

Neuroscience

Transmission routes of spreading protein particles

In diseases like Alzheimer's and Parkinson's endogenous proteins accumulate in the brain, eventually leading to the death of nerve cells. These deposits, which consist of abnormally formed proteins, are supposed to migrate ...

Genetics

Yeast provides genetic clues on drug response

Why do people respond differently to the same drug? For the first time, researchers have untangled genetic and environmental factors related to drug reactions, bringing us a step closer to predicting how a drug will affect ...

Medical research

Declaring a truce with our microbiological frienemies

Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.

Diseases, Conditions, Syndromes

Thrush: Zinc may prevent yeast infections—new research

Around a half-billion women experience a vaginal yeast infection (thrush) every year—with around 140 million women suffering from multiple infections throughout their lifetime.

Oncology & Cancer

An unexpected role for epigenetic enzymes in cancer

To better understand how cancer initiates and spreads, Yale associate professor of pathology Qin Yan turned to the field of epigenetics, which examines changes in the expression of genes and proteins that do not affect the ...

page 8 from 11